#EAN2018 – Spinal Cord Atrophy Better Marker of Physical Disability in SPMS Than Brain Volume Loss, Study Reports
Atrophy seen in areas of the spinal cord is a better predictor of physical disability in secondary progressive multiple…
Articles by Jose Marques Lopes, PhD
Medical Cannabis Favored to Treat MS Spasticity and Other Ills by Doctors in Australia, Survey Finds
Most general practitioners in Australia favor prescribing medical cannabis to treat spasticity in multiple sclerosis (MS) or pain in select…
Cannabidiol Compound, EHP-101, Seen to Prevent Nerve Cell Damage in MS Mouse Model
An investigational cannabidiol-derived compound called EHP-101 may help to boost remyelination, prevent nerve cell damage and lower the reactivity…
Vagus Nerve Signals Could Work as ‘Early Warning System’ for Inflammation in MS and Other Disease, Study Says
A new way of interpreting inflammatory signals using the vagus nerve — which carries such signals from throughout the body…
Atrophy of Brain Lesions Predicts Disability in MS, 10-year Study Finds
Atrophy (shrinkage) of brain lesions correlates with physical disability in patients with multiple sclerosis (MS), new research reports. The study,…
Chemical that Stimulates Estrogen Receptors Seen to Promote Myelin Repair Through ‘Good’ Inflammation in Mouse MS Model
A chemical compound called indazole chloride promotes repair of myelin, the protective layer of nerve fibers, through “beneficial” inflammation in…
2 Common Tests Used to Assess Deficits in MS Produce Different Results, Study Finds
Learning impairments in multiple sclerosis (MS) are detected differently by the two most commonly used neuropsychological tests, a new study…
Brain Stimulation Done at Slower Rates May Be Best for MS and Other Patients as Neurons ‘Tire,’ Study Says
A non-invasive procedure using magnetic pulses to stimulate the brain may be more effective in treating multiple sclerosis (MS) and other patients…
Impact of Early Aggressive vs. Standard Therapy on Disability in RRMS To Be Tested in Trial
A Johns Hopkins University-initiated clinical trial is starting to enroll an estimated 900 relapsing-remitting multiple sclerosis (RRMS) patients to assess…
B-Cell Changes May Predict Conversion from Clinically Isolated Syndrome to MS, Study Suggests
B-cell alterations in peripheral blood may predict the conversion of clinically isolated syndrome (CIS) to multiple sclerosis (MS),…
Akili to Advance Potential Video Game-Based Therapies for MS, Other Disorders
Akili Interactive announced it has received a $55 million in financing to develop a digital platform to possibly treat people…
Molecule Whose Fragments Appear to Block Myelin Repair Identified in Study
A molecule responsible for preventing the repair of white matter in the brain, a process critical to treating multiple sclerosis (MS)…
Subtle Myelin Damage May Occur Before Inflammatory Reactions in MS, Study Suggests
Subtle changes in myelin, the protective layer of nerve fibers, may be an early event in multiple sclerosis (MS)…
Fracking Chemicals May Lead to Earlier Onset, More Severe MS, Mouse Study Suggests
Exposure to fracking chemicals during pregnancy may aggravate multiple sclerosis (MS) severity and induce an earlier start of symptoms,…
Patients’ Walking Abilities in ‘Real-Life’ Ably Measured Using Wearable Sensors in UK Study
Pairing wearable sensors with a computer program enables effective monitoring of the way multiple sclerosis (MS) patients walk in “real…
Livestock Disease Toxin May Lead to Development of MS, Study Suggests
Exposure to epsilon toxin (ETX), which is mainly found in livestock, could be linked to the development of multiple…
#AAN2018 – New AAN Guideline Favors Advising Patients to Use DMTs Early in Disease Course
A new American Academy of Neurology (AAN) guideline recommends that multiple sclerosis (MS) patients in general be counseled to…
#AAN2018 – Siponimod Lessens Risk of SPMS Progression Independent of Relapses, Trial Data Show
Novartis’ investigational oral treatment siponimod (BAF312) reduces the risk of disability progression in patients with secondary progressive multiple…
Epstein-Barr Virus May Increase Risk of MS, Other Diseases, Study Reports
Infection with the common Epstein-Barr virus (EBV) may increase the risk of developing multiple sclerosis (MS), a new report…
#AAN2018 – Ocrevus Data Support Sustained Efficacy, Ability to Aid Cognition in RMS Patients
Treatment with Ocrevus (ocrelizumab) shows sustained efficacy and an ability to improve cognition in patients with relapsing multiple sclerosis (MS),…
US, Australia Issue Patents on Sonde’s Voice-analysis Technology for Diagnosing Diseases
The United States and Australia have issued patents on Sonde Health‘s voice-analysis technology for diagnosing and monitoring multiple sclerosis and…
Professor Earns Research Award for Establishing Use of MRI to Improve MS Diagnosis, Understanding
Professor Frederik Barkhof, MD, PhD, has won the 2018 John Dystel Prize for Multiple Sclerosis Research for pioneering…
#CMSC2018 – Closing Lecture to Focus on Best Use of DMTs
When and how to best use disease-modifying therapies (DMTs) in multiple sclerosis depends on key treatment decisions that, partly because the…
New MS Therapy Company, Pipeline, to Focus on Rejuvenating Coating That Protects Nerve Cells
A new company called Pipeline Therapeutics will focus on developing next-generation therapies for regenerating the key nerve-protection process that…
1st Patient Enrolls in Phase 3 Trial of ADS-5102 as Way of Improving Walking Ability, Adamas Announces
A Phase 3 trial testing an oral once-a-day therapy — ADS-5102 (amantadine) extended release capsules — in multiple sclerosis (MS)…
Pain Treatment During Labor Does Not Increase Risk of MS Relapses After Delivery, Study Finds
A certain type of pain-relief treatment during childbirth does not increase the risk that women with multiple sclerosis will have…
Flex Pharma’s MS Treatment Candidate FLX-787 Improves Cramps, Stiffness, Phase 2 Trial Shows
Topline results of an exploratory Phase 2 clinical trial revealed that Flex Pharma‘s treatment candidate FLX-787 improves muscle…
Evidence Supports Safety, Effectiveness of Medical Cannabis in MS, Cancer, Other Diseases
Medical cannabis is a safe and effective treatment for pain relief and should be integrated into current clinical practice, according…
Treatment with Umbilical Cord Stem Cells Safe with Sustained Benefits for MS, Trial Shows
Treatment with umbilical cord stem cells was found to be safe and leads to sustained improvements in disability and brain lesions…
Poorer Sense of Smell Can Be Evident Even in Early Stages of MS, Study Says
People with multiple sclerosis (MS) can indeed have a poorer-than-usual sense of smell, with problems possibly starting at early…